Adherex Technologies Inc. - Product Pipeline Review - 2013


Naperville, IL -- (SBWIRE) -- 01/27/2014 -- Reportstack, provider of premium market research reports announces the addition of Adherex Technologies Inc. - Product Pipeline Review - 2013 market report to its offering
Adherex Technologies Inc. - Product Pipeline Review - 2013


Global Market Directs pharmaceuticals report, Adherex Technologies Inc. - Product Pipeline Review - 2013 provides data on the Adherex Technologies Inc.s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from proprietary databases, Adherex Technologies Inc.s corporate website, SEC filings, investor presentations and featured press releases, both from Adherex Technologies Inc. and industry-specific third party sources, put together by team.


- Adherex Technologies Inc. - Brief Adherex Technologies Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Adherex Technologies Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Adherex Technologies Inc. with complete description of the products developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Adherex Technologies Inc.s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Adherex Technologies Inc.s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Adherex Technologies Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Adherex Technologies Inc.s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Adherex Technologies Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Adherex Technologies Inc. and identify potential opportunities in those areas.

To view the table of contents for this market research report please visit
Roger Campbell
United States
Ph: 888-789-6604